← Back to all trials
Not Yet Recruiting
NCT07712575
A Study of V132 in Healthy Older Participants (V132-001)
Conditions: Healthy
Sex: All
Ages: 50 Years – 75 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 280
Sponsor: Merck Sharp & Dohme LLC
Summary
The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.
Eligibility Criteria
Inclusion Criteria:
The key inclusion criteria include but are not limited to the following:
* Is in good health
* Has body mass index (BMI) within 18.0 to 35.0 kg/m\^2 (inclusive)
Exclusion Criteria:
The key exclusion criteria include but are not limited to the following:
* Has a history of invasive pneumococcal disease or known history of other culture-positive pneumococcal disease within 3 years prior to receiving study vaccination
* Has received a pneumococcal polysaccharide vaccine in the previous 10 years, has received any pneumococcal conjugate vaccine at any time prior to this study
Source: ClinicalTrials.gov (NCT07712575). StuddyBuddy aggregates publicly available trial information.
